Investigation Overview
August 14, 2017 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of NxStage Medical, Inc. (NASDAQ:NXTM), was announced concerning whether the takeover of NxStage Medical, Inc. by Fresenius Medical Care for $30.00 per share is unfair to NASDAQ:NXTM stockholders. The investigation by a law firm concerns whether certain officers and director...
You must register (for free) or login to view the entire investigation.